Cargando…

Comparative evaluation of efficacy and safety of drotaverine versus mebeverine in irritable bowel syndrome: A randomized double-blind controlled study

BACKGROUND: Drotaverine and Mebeverine are used for alleviating the pain of IBS, but the evidence for their efficacy is scarce. In this randomised control study, we evaluated and compared their efficacy in improving severity, frequency of pain and its associated symptoms. METHODS: Patients fulfillin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rai, Ramesh R., Nijhawan, Sandeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265406/ https://www.ncbi.nlm.nih.gov/pubmed/33642357 http://dx.doi.org/10.4103/sjg.SJG_266_20

Ejemplares similares

Efficacy and Safety of Drotaverine Hydrochloride in Irritable Bowel Syndrome: A Randomized Double-Blind Placebo-Controlled Study
por: Rai, Ramesh R., et al.
Publicado: (2014)

Randomized controlled study of efficacy and safety of drotaverine hydrochloride in patients with irritable bowel syndrome
por: Xue, Xing-cun, et al.
Publicado: (2017)

The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome—A Systematic Review
por: Daniluk, Jaroslaw, et al.
Publicado: (2022)

A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial
por: El-Haggar, Sahar M, et al.
Publicado: (2022)

Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?
por: Chakraborty, Dwaipayan Sarathi, et al.
Publicado: (2019)

A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial [Retraction]
Publicado: (2022)

Drotaverine-induced priapism
por: Kanbur, Ajay Shyam, et al.
Publicado: (2021)

Drotaverine to shorten the duration of labour in primigravidas: a randomised, double-blind, placebo-controlled trial
por: Ikeotuonye, Arinze Chidiebele, et al.
Publicado: (2022)

Neuromuscular electrical stimulation as an adjunctive therapy to drotaverine hydrochloride for treating patients with diarrhea-predominant irritable bowel syndrome: A retrospective study
por: Wang, Jian-kui, et al.
Publicado: (2018)

Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website
por: Everitt, Hazel, et al.
Publicado: (2013)

Efficacy and Safety of Tiropramide in the Treatment of Patients With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-blind, Non-inferiority Trial, Compared With Octylonium
por: Lee, Kang Nyeong, et al.
Publicado: (2014)

Efficacy and Safety of a Novel Herbal Medicine in the Treatment of Irritable Bowel Syndrome: A Randomized Double-Blinded Clinical Trial
por: Bordbar, Ghasem, et al.
Publicado: (2020)

Efficacy and Safety of New Lactobacilli Probiotics for Unconstipated Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Oh, Joo Hyun, et al.
Publicado: (2019)

Simultaneous Spectrophotometric Determination of Drotaverine Hydrochloride and Paracetamol in Tablet
por: Mahaparale, Sonali, et al.
Publicado: (2010)

Efficacy and safety of vibegron for the treatment of irritable bowel syndrome in women: Results of a randomized, double‐blind, placebo‐controlled phase 2 trial
por: Lacy, Brian E., et al.
Publicado: (2022)

pH-Sensitive Mebeverine Microspheres for Colon Delivery
por: Dandagi, P. M., et al.
Publicado: (2009)

Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial
por: Ricci, Chiara, et al.
Publicado: (2022)

Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
por: Vázquez-Frias, Rodrigo, et al.
Publicado: (2022)

Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website. (MIBS trial)
por: Everitt, Hazel A, et al.
Publicado: (2010)

Drug-Loaded Silver Nanoparticles—A Tool for Delivery of a Mebeverine Precursor in Inflammatory Bowel Diseases Treatment
por: Todorova, Mina, et al.
Publicado: (2023)

Efficacy and safety of lactulose for the treatment of irritable bowel syndrome
por: Chen, Hong-Bin, et al.
Publicado: (2019)

Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial
por: Ballou, Sarah, et al.
Publicado: (2017)

Mebeverine for Pediatric Functional Abdominal Pain: A Randomized, Placebo-Controlled Trial
por: Pourmoghaddas, Zahra, et al.
Publicado: (2014)

Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant]
por: Gupta, Anil Kumar, et al.
Publicado: (2021)

A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome
por: Khalilian, Alireza, et al.
Publicado: (2021)

The Influence of the Intergranular Superdisintegrant Performance on New Drotaverine Orodispersible Tablet Formulations
por: Vlad, Robert-Alexandru, et al.
Publicado: (2023)

Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial
por: Ivashkin, Vladimir T., et al.
Publicado: (2022)

Efficacy and safety of linaclotide in patients with irritable bowel syndrome with constipation: Chinese sub‐cohort analysis of a phase III, randomized, double‐blind, placebo‐controlled trial
por: Peng, Li Hua, et al.
Publicado: (2022)

Soy Isoflavones Supplementation for Patients with Irritable Bowel Syndrome: A Randomized Double Blind Clinical Trial
por: Jalili, Mahsa, et al.
Publicado: (2015)

Kimchi improves irritable bowel syndrome: results of a randomized, double-blind placebo-controlled study
por: Kim, Hee-Young, et al.
Publicado: (2022)

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study
por: El-Salhy, Magdy, et al.
Publicado: (2020)

Compatibility of Drotaverine Hydrochloride with Ibuprofen and Ketoprofen Nonsteroidal Anti-Inflammatory Drugs Mixtures
por: Soare, Andreia-Cristina, et al.
Publicado: (2022)

Efficacy of Chinese Herbal Medicine for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
por: Zhu, Jia-Jie, et al.
Publicado: (2016)

A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation
por: Mezzasalma, Valerio, et al.
Publicado: (2016)

A new acupuncture method for management of irritable bowel syndrome: A randomized double blind clinical trial
por: Rafiei, Rahmatollah, et al.
Publicado: (2014)

Efficacy and safety of non-pharmacological interventions for irritable bowel syndrome in adults
por: Dai, Yun-Kai, et al.
Publicado: (2020)

In Silico, In Vitro, and Ex Vivo Biological Activity of Some Novel Mebeverine Precursors
por: Milusheva, Miglena, et al.
Publicado: (2023)

A multicenter double-blind, placebo-controlled randomized trial to evaluate the safety and efficacy of bovine colostrum in the treatment of severe alcoholic hepatitis (SAH)
por: Sidhu, S. S., et al.
Publicado: (2023)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial
por: Zheng, Ya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n73n2kjo4hhjdvmvtb18iera5r